CIPLA
|
The Current P/E Ratio of CIPLA is 29.06.
Share Price | ₹1,347.7 | Apr 23,2024 |
Market Cap | ₹108,813.3 Cr | |
Earnings-TTM | ₹3,744.0 Cr | TTM-Consolidated Results |
Price/Earnings | 29.06x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of CIPLA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹108,813.3 Cr] as on Apr 23,2024
(/) Earnings [ ₹3,744.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 29.06x ]
Thus, for CIPLA , the investors are currently willing to pay 29.06 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of CIPLA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of CIPLA over the last five years.
Historical PE (Price/Earnings) ratio chart of CIPLA
PE Ratio Performance Analysis for CIPLA
- CIPLA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 27.18x.
- CIPLA 's operated at median p/e ratio of 27.34x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/e ratio peaked in Mar2022 at 32.65x.
- CIPLA 's p/e ratio hit its five-year low in Mar2020 of 22.05x.
How does CIPLA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
CIPLA | 3,744.03 | 29.06 | 108,813.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 39.56 | 356,001.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.07 | 99,325.3 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 32.68 | 96,553.2 |
DIVIS LABORATORIES LTD | 1,382.97 | 72.36 | 100,075.0 |
MANKIND PHARMA LTD | 1,743.30 | 55.01 | 95,896.9 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 59.72 | 89,224.4 |
LUPIN LTD | 1,809.74 | 39.80 | 72,033.6 |
AUROBINDO PHARMA LTD | 2,777.89 | 23.05 | 64,043.1 |
ABBOTT INDIA LTD | 1,145.58 | 47.75 | 54,704.8 |
ALKEM LABORATORIES LTD | 1,574.66 | 35.69 | 56,202.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs CIPLA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.07x |
Max industry PE | 72.36x |
Median industry PE | 39.56x |
Average industry PE | 41.25x |
You may also like the below Video Courses